Brownlee, WJ
32  results:
Search for persons X
?
 
?
2

Differential diagnosis of suspected multiple sclerosis: an ..:

Solomon, AJ ; Arrambide, G ; Brownlee, WJ...
https://discovery.ucl.ac.uk/id/eprint/10174655/2/Solomon_Differential%20diagnosis%20of%20suspected%20multiple%20sclerosis-%20an%20updated%20consensus%20approach_AAM.pdf.  , 2023
 
?
3

COVID-19 and high-efficacy multiple sclerosis therapies: Ti..:

Brownlee, WJ
https://discovery.ucl.ac.uk/id/eprint/10126617/1/COVID-19%20and%20high-efficacy%20multiple%20sclerosis%20therapies%20Time%20for%20business%20as%20usual.pdf.  , 2020
 
?
4

Longitudinal Assessment of Multiple Sclerosis with the Brai..:

Cole JH ; Raffel J ; Friede T...
info:eu-repo/semantics/altIdentifier/pmid/32285956.  , 2020
 
?
5

Longitudinal assessment of multiple sclerosis with the brai..:

Cole, JH ; Raffel, J ; Friede, T...
https://discovery.ucl.ac.uk/id/eprint/10095305/1/Barkhof_ana.25746.pdf.  , 2020
 
?
6

Cortical grey matter sodium accumulation is associated with..:

Brownlee, WJ ; Solanky, B ; Prados, F...
https://discovery.ucl.ac.uk/id/eprint/10074016/1/Brownlee_CIS_Sodium_Final_JNNP%2012.09.18_References_Revision%201_Final.pdf.  , 2019
 
?
7

Early imaging predictors of long-term outcomes in relapse-o..:

Brownlee, WJ ; Altmann, DR ; Prados Carrasco, F...
https://discovery.ucl.ac.uk/id/eprint/10072582/3/Brownlee_CIS_Predictors%20of%20long%20term%20outcomes_Revision%201_Final_Clean%20copy.pdf.  , 2019
 
?
8

New MS diagnostic criteria in practice:

De Angelis, F ; Brownlee, WJ ; Chard, DT.
https://discovery.ucl.ac.uk/id/eprint/10060911/1/Chard_pn_new_diagnostic_criteria_revision_clean.pdf.  , 2019
 
?
9

A practical approach to assessing and managing sexual dysfu..:

Li, V ; Haslam, C ; Pakzad, M..
https://discovery.ucl.ac.uk/id/eprint/10092298/2/Figure%201.tif.  , 2019
 
?
10

Instead of tweaking the diagnostic criteria for MS in those..:

Brownlee, WJ
https://discovery.ucl.ac.uk/id/eprint/10092999/3/Brownlee_Controversies_Misdiagnosis_Main%20document_Revision%2007.11.18.pdf.  , 2019
 
?
11

Switching from natalizumab to alemtuzumab in patients with ..:

John, N ; Carroll, A ; Brownlee, WJ.
https://discovery.ucl.ac.uk/id/eprint/10075049/3/John_Switchers%20letter%20v.5.0_reviewersJNNP_04-04-2019_Revision%202.0_WB_NJ_JC_15.04.19%20%28FINAL%20clean%29.pdf.  , 2019
 
?
12

Disease-modifying therapies for multiple sclerosis:

De Angelis, F ; John, NA ; Brownlee, WJ
https://discovery.ucl.ac.uk/id/eprint/10067166/1/De%20Angelis_BMJ-therapeutics-multiple-sclerosis-accepted_draft.pdf.  , 2018
 
?
13

Clinical commentary on 'Late-onset neutropenia and neurolog..:

Hacohen, Y ; Brownlee, WJ
https://discovery.ucl.ac.uk/id/eprint/10055963/1/Brownlee_Rituximab%20neutropenia%20editorial%20040418_v2.pdf.  , 2018
 
?
15

Do spinal cord lesions matter in patients with clinically i..:

Brownlee, WJ
https://discovery.ucl.ac.uk/id/eprint/10040438/1/Brownlee_Main%20document_Revised%2022.11.17.pdf.  , 2018
 
1-15